Effect of truncated-ApoE4 overexpression on tau phosphorylation in cultured N2a cells

Abstract

The carboxyl-terminal amino acids 272–299-truncated apoE4 (Δ272–299) is the main fragments of apoE4 hydrolysate in neurons. The effects of truncated-ApoE4 (Δ272–299) overexpression on tau phosphorylation in cultured N2a cells were investigated. The truncated-apoE4 (Δ272–299) cDNA was subcloned into pEGFP-c3 to form recombinant pEGFP-T-apoE4. pEGFP-c3, pEGFP-T-apoE4 and pEGFP-apoE4 were transfected into N2a cells respectively by lipofectamine 2000 method. After 24–48 h, tau phosphorylation was detected by Western blot assay and glycogen synthase kinase-3 (GSK-3) activity by using GSK-3 activity assay. The results showed that the overexpression of both full length-apoE4 and truncated apoE4 fragments in N2a cells induced a dramatic increase in phosphorylation of tau at Ser202 sites and the activation of GSK-3 as compared with untransfected cells, most significantly in the cells transfected with pEGFP-T-apoE4 (P<0.05). It as concluded that in vitro overexpression of truncated-ApoE4 (Δ272–299) can result in tau hyperphosphorylation in N2a cells by activating GSK-3, suggesting truncated-ApoE4 (Δ272–299) might contribute the pathogenesis of Alzheimer disease.

Keywords

truncated-ApoE4 / tau / glycogen synthase kinase-3 / Alzheimer disease

References

[1] FaganA M, HoltzmanD M. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo. Microsc Res Tech, 2000, 50(4): 297-304

[2] HansH. Bock, JossinYves. Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination. J Biol Chem, 2003, 278(40): 38 772-38 779

[3] HuangY D, LiuX Q. Apolipoprotein E fragments present in Alzheimer’s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci USA, 2001, 98(15): 8838-8843

[4] HanX L, ChengH. Novel role for apolipoprotein E in the central nervous system. J Biol Chem, 2003, 278(10): 8043-8051

[5] Cedazo-MinguezA, PopescuB, Blanco-MillanJ M, et al.. Apolipoprotein E and beta-amyloid (1–42) regulation of glycogen synthase kinase-3beta. J Neurochem, 2003, 87(5): 1152-1164

[6] Ye S M, Huang Y D, Mullendorff Ket al. Apolipoprotein (apo) E4 enhances amyloid peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target. PNAS, 102 (52): 18 700–18 705

[7] KosikK S. The molecular and cellular biology of tau. Brain Pathol, 1993, 3(1): 39-43

[8] GoedertM. tau protein and the neurofibrillary pathology of Alzheimer’s disease. Trends Neurosci, 1993, 16: 460-465

[9] PeiJ J, TanakaT, TungY C, et al.. Distribution, levels, and activity of GSK-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol, 1997, 56: 70-78